According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM ) is NZ$79.97 Billion. In 2024 the company made a revenue of NZ$85.64 Billion an increase over the revenue in the year 2023 that were of NZ$71.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.